Back/IDEXX Advances Pet Health with New Kidney Disease Detection Technology
canada·May 22, 2026·idxx

IDEXX Advances Pet Health with New Kidney Disease Detection Technology

ED
Editorial
Cashu Markets·2 min read
IDEXX Advances Pet Health with New Kidney Disease Detection Technology
TL;DR
  • IDEXX Laboratories advances pet health with innovative diagnostic solutions.
  • The company enhances Catalyst chemistry profiles by adding the SDMA kidney biomarker.
  • Early kidney disease detection helps veterinarians manage pet health effectively.

IDEXX Laboratories (IDXX) focuses on advancing pet health through innovative diagnostic solutions. The company recently makes a notable enhancement to its Catalyst in-clinic chemistry profiles by incorporating the SDMA (Symmetric Dimethylarginine) kidney biomarker. This development allows veterinarians in the United States and Canada to identify kidney disease in pets at an earlier stage, utilizing routine blood work. The early detection of kidney issues is critical in managing the health of pets, as these diseases may remain unnoticed until they reach an advanced stage.

Revolutionizing Kidney Disease Detection

With the integration of the SDMA test, veterinary clinics can now offer a vital assay within their existing Catalyst profiles without the need for additional investments in expensive equipment or alterations to their workflows. This seamless integration enhances the potential for early intervention, which is essential for improving health outcomes in pets suffering from kidney disease. By addressing this significant health challenge, IDEXX not only supports veterinarians in providing better care but also reinforces its leadership position in the veterinary diagnostics market.

Commitment to Cost-Effective Veterinary Care

This strategic update aligns with international veterinary kidney disease guidelines, highlighting IDEXX's commitment to advancing pet healthcare while balancing cost-effectiveness within veterinary practices. By incorporating the SDMA biomarker into routine diagnostics, IDEXX empowers veterinarians to make informed, timely decisions that enhance patient care. This initiative reflects the company's ongoing dedication to innovation in veterinary science and improving the quality of life for pets.

Setting the Standard in Veterinary Diagnostics

By leading the incorporation of the SDMA biomarker into their diagnostics, IDEXX Laboratories positions itself at the forefront of veterinary diagnostics. This enhancement not only provides veterinarians with the tools they need to detect kidney disease early but also assures pet owners that they are accessing cutting-edge technology for the wellbeing of their animals. As the demand for reliable and efficient veterinary diagnostics grows, IDEXX continues to innovate and adapt, ensuring they meet the evolving needs of both veterinarians and pet owners alike.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...